Related Experiment Video
Updated: Aug 28, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs
Corrado Girmenia1, Wilma Barcellini2, Paola Bianchi2
1Hematology, Department of Hematology, Oncology and Dermatology, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Insights
Experts identified key unmet needs in managing infectious risks for paroxysmal nocturnal hemoglobinuria (PNH) patients on complement inhibitors (CIs). Recommendations focus on enhancing infection prevention and non-pharmacological strategies for better CI therapy outcomes.
Area of Science:
- Hematology
- Immunology
- Clinical Medicine
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder.
- Terminal complement inhibitors (CIs) like eculizumab are effective PNH treatments.
- Infectious complications pose a significant risk for PNH patients on CIs.
Purpose of the Study:
- To identify and address unmet clinical needs (UCNs) in managing infectious risk in PNH patients.
- To establish consensus on optimizing infection prevention and management strategies.
- To propose advancements in clinical practice for complement inhibitor therapy.
Main Methods:
- A panel of experts was convened to discuss UCNs using the Delphi technique.
- Clinically relevant UCNs for PNH patients receiving or considering CIs were selected.
- Consensus opinions and proposals for clinical practice were developed.
Main Results:
- Key UCNs identified include optimizing infection prevention measures.
- Developing non-pharmacological infectious risk-mitigation strategies is crucial.
- Improving the management of disease exacerbation during infectious complications is needed.
Conclusions:
- Addressing these UCNs can improve the safety and efficacy of CI therapy in PNH.
- The findings will inform future clinical practice and research in PNH management.
- Enhanced strategies are needed to mitigate infectious risks associated with CIs.
Abstract:
This article presents the results of group discussion among an ad hoc constituted panel of experts aimed at identifying and addressing unmet clinical needs (UCNs) in the management of infectious risk associated with eculizumab or new terminal complement inhibitors (CIs) in paroxysmal nocturnal hemoglobinuria (PNH). With the Delphi technique, the most clinically relevant UCNs in PNH patients candidate to or on terminal CI were selected. They resulted to be: optimizing the infection prevention measures; developing non pharmacological infectious risk-mitigation strategies; improving the management of disease exacerbation during infectious complications. For each of these issues consensus opinions were provided and, when appropriate, proposals for advancement in clinical practice were addressed. The hope is that this comprehensive overview will serve to improve the practice of CIs therapy and inform the design and implementation of new studies in the field.
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Related Concept Videos
Endocarditis IV: Nursing Management
Nephrotic Syndrome III : Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....